Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 792, Issue 2, 2003, Pages 353-362

  Kappelhoff, Bregt S ^a   Rosing, Hilde ^a   Huitema, Alwin D R ^a   Beijnen, Jos H ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Efavirenz; Nevirapine

Indexed keywords

BIOASSAY; DRUG THERAPY; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; PRECIPITATION (CHEMICAL); VIRUSES;

HUMAN PLASMA;

BIOMEDICAL ENGINEERING;

ACETONITRILE; CARBAMAZEPINE; CHEMICAL COMPOUND; EFAVIRENZ; NEVIRAPINE; NUCLEOSIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); DILUTION; DRUG MONITORING; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; LIQUID CHROMATOGRAPHY; METHODOLOGY; PRECIPITATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; STANDARD; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037969367     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(03)00325-8     Document Type: Article

References (12)

1. Adkins J.C., Noble S. Drugs. 56:1998;1055.
2. Young S.D., Britcher S.F., Tran L.O., Payne L.S., Lumma W.C., Lyle T.A., Huff J.R., Anderson P.S., Olsen D.B., Carroll S.S., Pettibone D.J., O'Brien J.A., Ball R.G., Balani S.K., Lin J.H., Chen I.-W., Schleif W.A., Sardana V.V., Long W.J., Byrnes V.W., Emini E.A. Antimicrob. Agents Chemother. 39:1995;2602.
3. Marzolini C., Telenti A., Decosterd L.A., Greub G., Biollaz J., Buclin T. AIDS. 15:2001;71.
4. Veldkamp A.I., Weverling G.J., Lange J.M.A., Montaner J.S.G., Reiss P., Cooper D.A., Vella S., Hall D., Beijnen J.H., Hoetelmans R.M.W. AIDS. 15:2001;1089.
5. Tribut O., Arvieux C., Michelet C., Chapplain J.-M., Allain H., Bentué-Ferrer D. Ther. Drug Monit. 24:2002;554.
6. Rezk N.L., Tidwell R.R., Kashuba A.D.M. J. Chromatogr. B. 774:2002;79.
7. Aymard G., Legrand M., Trichereau N., Diquet B. J. Chromatogr. B. 744:2000;227.
8. Simon V.A., Thiam M.D., Lipford L.C. J. Chromatogr. A. 913:2001;447.
9. Titier K., Lagrange F., Péhourcq F., Edno-Mcheik L., Moore N., Molimard M. Ther. Drug Monit. 24:2002;417.
10. http://www.fda.gov/cvm. Guidance for Industry, Bioanalytical method validation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Dated May 2001, BP.
11. Rosing H., Man W.Y., Doyle E., Bult A., Beijnen J.H. J. Liq. Chromatogr. Relat. Technol. 23:2000;329.
12. Veldkamp A.I., van Heeswijk R.P.G., Meenhorst P.L., Mulder J.W., Lange J.M.A., Beijnen J.H., Hoetelmans R.M.W. J. Chromatogr. B. 734:1999;55.